民行(01988.HK):8月末民企貸款餘額按年增8.2%
民生銀行(01988.HK)(600016.SH)行長鄭萬春在銀行業保險業例行新聞發布會上表示,截至8月末,民行民營企業貸款餘額1.58萬億元人民幣(下同),比年初增長792.7億元,與去年同期比增加8.2%;2020年首八個月,累計發放民企貸款近1.1萬億元。
今年上半年,民行對公累計新增疫情防控授信579.5億元,發行防疫專項同業存單37.9億元,支持產業鏈協同復工復產。截至8月末,民生銀行累計通過展期、續貸、合同調整等方式為中小微企業延期償還本金1,193億元,延期付息累計金額31億元。(ta/a) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.